Trastuzumab rezetecan
Product Specifications
CAS Number
2924909-11-3
Target
EGFR|||Antibody-Drug Conjugates (ADCs)
Related Pathways
Angiogenesis|||Antibody-drug Conjugate/ADC Related|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors
Bioactivity
Trastuzumab rezetecan (SHR-A1811) is an antibody-drug conjugate (ADC) targeting HER2. It is composed of a humanized anti-HER2 antibody, a cleavable linker MC-Gly-Gly-Phe-Gly, and an effective payload of the topoisomerase I inhibitor Rezetecán. Trastuzumab rezetecan is utilized in the research of HER2-positive breast cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2070281-01 0.1 mL
APC-Linked Polyclonal Antibody to Fasciculation And Elongation Protein Zeta 2 (FEz2)
Ask
View Details MBS2070281-02 0.2 mL
APC-Linked Polyclonal Antibody to Fasciculation And Elongation Protein Zeta 2 (FEz2)
Ask
View Details 
MBS2070281-03 0.5 mL
APC-Linked Polyclonal Antibody to Fasciculation And Elongation Protein Zeta 2 (FEz2)
Ask
View Details 
MBS2070281-04 1 mL
APC-Linked Polyclonal Antibody to Fasciculation And Elongation Protein Zeta 2 (FEz2)
Ask
View Details MBS2070281-05 5 mL
APC-Linked Polyclonal Antibody to Fasciculation And Elongation Protein Zeta 2 (FEz2)
Ask
View Details MBS2070281-06 5x 5 mL
APC-Linked Polyclonal Antibody to Fasciculation And Elongation Protein Zeta 2 (FEz2)
Ask
View Details